Quetiapine-Induced Hyperprolactinemic Galactorrhea in an Adolescent Male

Quetiapine is an atypical antipsychotic agent with negligible prolactin-elevating properties. Although little data is available, studies show that it is both effective and safe in a variety of childhood mental illnesses. It has also been suggested to be the treatment of choice in antipsychotic-induced hyperprolactinemia in children. We report a case of a fourteen-year old male with conduct disorder who developed hyperprolactinemia and secondary galactorrhea with standard therapeutic dosages of quetiapine, which remitted shortly after a decrease in dose (German J Psychiatry 2006;9:118120).